A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2
320
about 2.7 years
18+
25 sites in AZ, CA, CO +9
What this study is about
This trial is testing a treatment called AZD1163 for people with rheumatoid arthritis. The goal is to see if this treatment helps improve symptoms and is safe.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take AZD1163
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change From Baseline in Disease Activity Score-C-Reactive Protein (DAS28-CRP) at Week 12
Secondary: Change From Baseline in Clinical Disease Activity Index (CDAI) at Week 12, Change From Baseline in Simplified Disease Activity Index (SDAI) at Week 12, Summary statistics to evaluate the PK of AZD1163
Immune